Sibutramine monotherapy in arterial hypertension combined with obesity
Aim. To investigate the potential of sibutramine (Meridia®) therapy in patients with obesity and arterial hypertension (AH); to assess sibutramine effects on blood pressure (BP), organ protection and quality of life (QoL) in individuals with obesity and AH, in comparison to traditional antihypertens...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2009-08-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1785 |